equal contribution.
Supplementary Materials:
Figure S1 --Expression levels of key molecules in the insulin pathway in WT and P301S mouse cortex Table S1 --Concentration of metformin in the plasma and brain of WT and P301S mice after treatment for 7 days Primary WT cortical neurons were incubated for 6 h in 2.5 µM metformin (Met), 10 µM rapamycin (Rapa), 10 µM dorsomorphin (Dorso) alone or in combination. Levels of tau, AMPK, S6 and phospho--S6 (pS6) were analyzed by western blot. A. Quantitative analysis of total tau in cortical neurons treated with or without metformin in the absence or presence of insulin. B. Quantitative analysis of total AMPK in neurons treated with metformin and dorsomorphin alone or in combination. C. Quantitative analysis of S6 in neurons incubated with metformin or rapamycin in the absence of insulin. D--E. Primary cortical neurons were transduced with S16H--Rheb and GFP, GFP control or not infected (NI) and treated with or without metformin for 6 h. D. Western blot analysis of Rheb, GFP and tubulin in transduced neurons. E. Western blot analysis of pS6, S6 and tubulin in transduced neurons treated with or without metformin. F--G. Quantitative analysis of S6 (F) and total tau (G) expression in transduced neurons. Total tau was detected using Tau5 antibody. [n], number of animals. 
